Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.4171
-7.06 %
$ 12.5 M
Market Cap
-0.27
P/E
PRPH - REVENUE
Revenue PRPH - ProPhase Labs, Inc.
44.4 M
LAST VALUE
-25.07%
2 YEAR CAGR
27.59%
5 YEAR CAGR
5.89%
10 YEAR CAGR